NORTH AMERICA METABOLOMICS MARKET FORECAST 2019-2027

  • You are here:
  • Home
  • Reports
  • NORTH AMERICA METABOLOMICS MARKET FORECAST 2019-2027

NORTH AMERICA METABOLOMICS MARKET FORECAST 2019-2027

The market for metabolomics in the region of North America is estimated to register a CAGR of 11.62% during the forecasted period. The extensive presence of several end-users focusing on treatment and studies of chronic disease, make use of metabolomics, and this is the primary driver of market growth in the region. The North America metabolomics market is segregated into two regions for market analysis, namely, the United States and Canada. The healthcare and research facilities in the North American region is well-known and well-established. In the US region, the pharmaceutical industry is one of the most prominent research-oriented organizations. The industry requires metabolomics to determine the clinical phenotypes that would aid in implementing a patient-centered drug development model.

NORTH AMERICA METABOLOMICS MARKET FORECAST 2019-2027

Request free sample

The market for metabolomics in the region of North America is estimated to register a CAGR of 11.62% during the forecasted period. The extensive presence of several end-users focusing on treatment and studies of chronic disease, make use of metabolomics, and this is the primary driver of market growth in the region.

The North America metabolomics market is segregated into two regions for market analysis, namely, the United States and Canada. The healthcare and research facilities in the North American region is well-known and well-established. In the US region, the pharmaceutical industry is one of the most prominent research-oriented organizations. The industry requires metabolomics to determine the clinical phenotypes that would aid in implementing a patient-centered drug development model. Another important factor boosting the growth of the metabolomics market in the North American region is the utilization benefits of metabolomics with regard to the swift detection of biomarkers. The active participation of the government in the form of investment and world-class resources for the research activities, is driving the growth of the metabolomics market in the region of Canada. Also, despite its recent introduction, the field of metabolomics is gaining traction in the region of Canada.

One of the eminent companies in the market, Agilent technologies, Inc., is a supplier of software, services, instruments to life sciences, diagnostics markets, etc. The manufacturing and R&D facilities of the company are in Australia, Singapore, Malaysia, Japan, China, Germany, Denmark, and Italy. The company has its headquarters in Santa Clara, California.

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP-DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • METABOLOMICS BIOINFORMATICS TOOLS AND SERVICES ARE THE FASTEST GROWING PRODUCT & SERVICE
      • BIOMARKER DISCOVERY IS THE WIDELY USED APPLICATION
      • CANCER IS THE MOST PREVALENT INDICATION
  1. MARKET DYNAMICS
    • MARKET SCOPE & DEFINITION
    • MARKET DRIVERS
      • GROWING INVESTMENTS IN THE METABOLOMICS DOMAIN BY THE PUBLIC AND PRIVATE SECTORS
      • RISE IN THE DEMAND FOR PERSONALIZED MEDICINES
      • UPSURGE IN THE INCIDENCES OF CHRONIC DISEASE
    • MARKET RESTRAINTS
      • LACK OF SKILLED PROFESSIONALS IN METABOLOMICS
      • HIGH COST OF THE INSTRUMENTS
    • MARKET OPPORTUNITIES
      • EMERGING APPLICATION OF METABOLOMICS IN HUMAN NUTRITION
      • GROWING USAGES IN THE EARLY DETECTION OF CHRONIC DISEASES
    • MARKET CHALLENGES
      • COMPLEX AND DIVERSE NATURE OF THE BIOLOGICAL SAMPLES
  1. MARKET BY PRODUCT & SERVICE
    • METABOLOMICS INSTRUMENTS
      • SEPARATION TECHNIQUE
      • DETECTION TECHNIQUE
    • METABOLOMICS BIOINFORMATICS TOOLS AND SERVICES
  2. MARKET BY APPLICATION
    • BIOMARKER DISCOVERY
    • DRUG DISCOVERY
    • TOXICOLOGY TESTING
    • NUTRIGENOMICS
    • FUNCTIONAL GENOMICS
    • PERSONALIZED MEDICINE
    • OTHER APPLICATION
  3. MARKET BY INDICATION
    • CANCER
    • CARDIOVASCULAR DISORDERS
    • NEUROLOGICAL DISORDERS
    • INBORN ERRORS OF METABOLISM
    • OTHER INDICATION
  4. KEY ANALYTICS
    • PORTER’S FIVE FORCES MODEL
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTE
      • BARGAINING POWER OF BUYERS
      • BARGAINING POWER OF SUPPLIERS
      • THREAT OF COMPETITIVE RIVALRY
    • VALUE CHAIN ANALYSIS
    • MARKET TRENDS
    • OPPORTUNITY MATRIX
  5. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
  1. COMPETITIVE LANDSCAPE
    • MARKET POSITION ANALYSIS
    • COMPANY PROFILES
      • AGILENT TECHNOLOGIES, INC.
      • APICAL SCIENTIFIC SDN BHD
      • BIOCRATES LIFE SCIENCES AG
      • BIO-RAD LABORATORIES, INC.
      • BRUKER CORPORATION
      • CREATIVE PROTEOMICS
      • DANAHER CORPORATION (SCIEX)
      • HUMAN METABOLOME TECHNOLOGIES, INC.
      • KORE TECHNOLOGY LIMITED
      • LECO CORPORATION
      • METABOLON INC.
      • PERKINELMER, INC.
      • SHIMADZU CORPORATION
      • THERMO FISHER SCIENTIFIC INC.
      • WATERS CORPORATION

TABLE LIST

TABLE 1: NORTH AMERICA METABOLOMICS MARKET, 2019-2027 ($ MILLION)

TABLE 2: NORTH AMERICA METAGENOMICS MARKET, BY PRODUCT & SERVICE, 2019-2027 ($ MILLION)

TABLE 3: NORTH AMERICA METABOLOMICS INSTRUMENTS MARKET, 2019-2027 ($ MILLION)

TABLE 4: NORTH AMERICA METABOLOMICS INSTRUMENTS MARKET, BY TYPE, 2019-2027 ($ MILLION)

TABLE 5: NORTH AMERICA SEPARATION TECHNIQUE MARKET, 2019-2027 ($ MILLION)

TABLE 6: NORTH AMERICA DETECTION TECHNIQUE MARKET, 2019-2027 ($ MILLION)

TABLE 7: NORTH AMERICA METABOLOMICS BIOINFORMATICS TOOLS AND SERVICES MARKET, 2019-2027 ($ MILLION)

TABLE 8: NORTH AMERICA METABOLOMICS MARKET, BY APPLICATION, 2019-2027 ($ MILLION)

TABLE 9: NORTH AMERICA BIOMARKER DISCOVERY MARKET, 2019-2027 ($ MILLION)

TABLE 10: NORTH AMERICA DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)

TABLE 11: NORTH AMERICA TOXICOLOGY TESTING MARKET, 2019-2027 ($ MILLION)

TABLE 12: NORTH AMERICA NUTRIGENOMICS MARKET, 2019-2027 ($ MILLION)

TABLE 13: NORTH AMERICA FUNCTIONAL GENOMICS MARKET, 2019-2027 ($ MILLION)

TABLE 14: NORTH AMERICA PERSONALIZED MEDICINE MARKET, 2019-2027 ($ MILLION)

TABLE 15: NORTH AMERICA OTHER APPLICATION MARKET, 2019-2027 ($ MILLION)

TABLE 16: NORTH AMERICA METABOLOMICS MARKET, BY INDICATION, 2019-2027 ($ MILLION)

TABLE 17: NORTH AMERICA CANCER MARKET, 2019-2027 ($ MILLION)

TABLE 18: NORTH AMERICA CARDIOVASCULAR DISORDERS MARKET, 2019-2027 ($ MILLION)

TABLE 19: NORTH AMERICA NEUROLOGICAL DISORDERS MARKET, 2019-2027 ($ MILLION)

TABLE 20: NORTH AMERICA INBORN ERRORS OF METABOLISM MARKET, 2019-2027 ($ MILLION)

TABLE 21: NORTH AMERICA OTHER INDICATION MARKET, 2019-2027 ($ MILLION)

TABLE 22: NORTH AMERICA METABOLOMICS MARKET, BY COUNTRY, 2019-2027 ($ MILLION)

TABLE 23: THE UNITED STATES METABOLOMICS MARKET, BY PRODUCT & SERVICE, 2019-2027 ($ MILLION)

TABLE 24: THE UNITED STATES METABOLOMICS MARKET, BY APPLICATION, 2019-2027 ($ MILLION)

TABLE 25: THE UNITED STATES METABOLOMICS MARKET, BY INDICATION, 2019-2027 ($ MILLION)

TABLE 26: CANADA METABOLOMICS MARKET, BY PRODUCT & SERVICE, 2019-2027 ($ MILLION)

TABLE 27: CANADA METABOLOMICS MARKET, BY APPLICATION, 2019-2027 ($ MILLION)

TABLE 28: CANADA METABOLOMICS MARKET, BY INDICATION, 2019-2027 ($ MILLION)

TABLE 29: METABOLOMICS COMPANY MARKET POSITION ANALYSIS, 2018

FIGURES LIST

FIGURE 1: NORTH AMERICA METABOLOMICS MARKET, 2019-2027 ($ MILLION)

FIGURE 2: NORTH AMERICA METAGENOMICS MARKET, BY METABOLOMICS INSTRUMENTS, 2019-2027 ($ MILLION)

FIGURE 3: NORTH AMERICA METABOLOMICS INSTRUMENTS MARKET, BY SEPARATION TECHNIQUE, 2019-2027 ($ MILLION)

FIGURE 4: NORTH AMERICA METABOLOMICS INSTRUMENTS MARKET, BY DETECTION TECHNIQUE, 2019-2027 ($ MILLION)

FIGURE 5: NORTH AMERICA METAGENOMICS MARKET, BY METABOLOMICS BIOINFORMATICS TOOLS AND SERVICES, 2019-2027 ($ MILLION)

FIGURE 6: NORTH AMERICA METABOLOMICS MARKET, BY BIOMARKER DISCOVERY, 2019-2027 ($ MILLION)

FIGURE 7: NORTH AMERICA METABOLOMICS MARKET, BY DRUG DISCOVERY, 2019-2027 ($ MILLION)

FIGURE 8: NORTH AMERICA METABOLOMICS MARKET, BY TOXICOLOGY TESTING, 2019-2027 ($ MILLION)

FIGURE 9: NORTH AMERICA METABOLOMICS MARKET, BY NUTRIGENOMICS, 2019-2027 ($ MILLION)

FIGURE 10: NORTH AMERICA METABOLOMICS MARKET, BY FUNCTIONAL GENOMICS, 2019-2027 ($ MILLION)

FIGURE 11: NORTH AMERICA METABOLOMICS MARKET, BY PERSONALIZED MEDICINE, 2019-2027 ($ MILLION)

FIGURE 12: NORTH AMERICA METABOLOMICS MARKET, BY OTHER APPLICATION, 2019-2027 ($ MILLION)

FIGURE 13: NORTH AMERICA METABOLOMICS MARKET, BY CANCER, 2019-2027 ($ MILLION)

FIGURE 14: NORTH AMERICA METABOLOMICS MARKET, BY CARDIOVASCULAR DISORDERS, 2019-2027 ($ MILLION)

FIGURE 15: NORTH AMERICA METABOLOMICS MARKET, BY NEUROLOGICAL DISORDERS, 2019-2027 ($ MILLION)

FIGURE 16: NORTH AMERICA METABOLOMICS MARKET, BY INBORN ERRORS OF METABOLISM, 2019-2027 ($ MILLION)

FIGURE 17: NORTH AMERICA METABOLOMICS MARKET, BY OTHER INDICATION, 2019-2027 ($ MILLION)

FIGURE 18: PORTER’S FIVE FORCE MODEL

FIGURE 19: THE UNITED STATES METABOLOMICSMARKET, 2019-2027 ($ MILLION)

FIGURE 20: CANADA METABOLOMICS MARKET, 2019-2027 ($ MILLION)

  1. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
  1. MARKET BY PRODUCT & SERVICE
    • METABOLOMICS INSTRUMENTS
      • SEPARATION TECHNIQUE
      • DETECTION TECHNIQUE
    • METABOLOMICS BIOINFORMATICS TOOLS AND SERVICES
  2. MARKET BY APPLICATION
    • BIOMARKER DISCOVERY
    • DRUG DISCOVERY
    • TOXICOLOGY TESTING
    • NUTRIGENOMICS
    • FUNCTIONAL GENOMICS
    • PERSONALIZED MEDICINE
    • OTHER APPLICATION
  3. MARKET BY INDICATION
    • CANCER
    • CARDIOVASCULAR DISORDERS
    • NEUROLOGICAL DISORDERS
    • INBORN ERRORS OF METABOLISM
    • OTHER INDICATION

To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now